Search

everythinglearnresearchcommunity

for

Search:↓

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

PHAs are promising biodegradable materials for medical and dental uses.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

S100A4 and NMIIA promote tumor growth in glioblastoma by enhancing blood vessel functions.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Botulinum toxin type A injections may help treat hidradenitis suppurativa.

AIMP1 can boost hair growth by increasing stem cell activity.

Oral JAK inhibitors help regrow hair in alopecia patients.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

The modified hair loss classification is more detailed but less user-friendly.

AI can help track and improve hair loss treatment outcomes.

Actin filaments help stabilize and reshape cell membranes.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Some cases of short anagen hair syndrome are linked to specific genetic variations that are also connected to male pattern baldness.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.